Kincell Bio

Overview

Kincell Bio is a cell therapy CDMO supporting programs across their full lifecycle, from early-phase process and analytical development through pivotal and commercial manufacturing. The company combines deep scientific expertise with personalized service and purpose-built U.S. facilities to deliver reliable, right-first-time manufacturing.

Services & Capabilities

Full Lifecycle Support

• Early-phase acceleration through risk-managed CMC roadmaps, design-of-experiments (DoE)-driven process optimization, and phase-appropriate analytics
• Late-phase development, commercialization, and commercial supply
• GMP manufacturing, analytics, and CMC strategy

Scientific Approach

• Science-first mindset guiding CMC development, analytics, manufacturing, and quality
• Advanced technologies and continuous process improvement
• Robust data generation and process controls to support regulatory advancement

Facilities

• Gainesville, FL: Early CMC and clinical supply manufacturing
• Research Triangle Park, NC: Pivotal and commercial manufacturing

Both facilities provide scalable and redundant GMP capacity, robust analytics, and expansion-ready infrastructure for long-term program continuity and supply reliability.

Partnership Model

Kincell operates as a transparent extension of client teams, emphasizing collaborative partnership, transparent communication, and tailored approaches to support each program's specific goals—whether speed, flexibility, or cost optimization.